Feasibility and validation studies ensure safety in the prescribers’ toolkit
Disease-treatment pathways are becoming increasingly complex, making diagnostic aids, assessment tools and treatment algorithms valuable in a prescribers’ toolkit. These tools are easy to incorporate into the general practice or hospital setting and facilitate a more rational and efficient disease-treatment-medication matrix.
ZEG Berlin engages with stakeholders to support the validation of different diagnosis tools and decision-making matrices. Feasibility and validation studies can be supplemented with utilization studies ensuring stakeholders have confidence that their product is both valid and effective.